Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00783302 · ClinicalTrials.gov registry record
Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care
A clinical trial, sponsored by GE Healthcare.
- Completed
- Registry status
- 885
- Enrollment target
NCT00783302 is a clinical trial that has completed, run by GE Healthcare. The registered enrollment target is 885 participants.
The verdict
NCT00783302 has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 885 participants
- Enrollment target
Study Summary
To assess prognostic value of CCTA examination in subjects who undergo CCTA as part of their medical care when compared to a standard of truth, i.e. subject outcomes during each follow-up period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 885 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00783302
The ClinicalTrials.gov registry entry for NCT00783302 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 885 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00783302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00783302 about?
NCT00783302 is a clinical study titled "Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care". To assess prognostic value of CCTA examination in subjects who undergo CCTA as part of their medical care when compared to a standard of truth, i.e. subject outcomes during each follow-up period.
What is the current status of trial NCT00783302?
This trial is currently completed. The enrollment target is 885 participants. The study started on 2008-09. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT00783302?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.